FGF-8 methods of use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S012200

Reexamination Certificate

active

07414019

ABSTRACT:
This invention features a method for treating a bone condition in a patient, e.g., a mammal, a human, a horse, a dog, or a cat. The method includes administering an effective amount of FGF-8, FGF-8 analog, or a FGF-8 agonist to the patient.

REFERENCES:
patent: 2003/0022170 (2003-01-01), Khodadoust
patent: WO 01/00662 (2001-01-01), None
Valta et al. Endorcrinol. 2006; 147: 2171-82.
Yao et al. Brain research. 1999; 818: 140-146.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Bork, 2000, Genome Research 10:398-400.
Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.
Doerks et al., 1998, Trends in Genetics 14:248-250.
Smith et al., 1997, Nature Biotechnology 15:1222-1223.
Brenner, 1999, Trends in Genetics 15:132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Blunt et al. “Overlapping Expression and Redundant Activation of Mesenchymal Fibroblast Growth Factor (FCF) Receptors by Alternatively Spliced FGF-8 Ligands”J. of Biol. Chem. 272(6):3733-3738 (1997).
Cornish et al. “Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo”Am. J. Physiol. 273:E1113-E1120 (1997).
Cornish et al. “Systemic administration of a novel octapeptide, amylin-(1—8), increases bone volume in male mice”Am. J. Physiol. 279:E730-E735 (2000).
Cornish et al. “Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes”Am. J. of Physiol. 277:E779-E783 (1999).
Genbank GI No. 1184864, Jan. 18, 1996.
Genbank GI No. 18461160, Jan. 30, 2002.
Genbank GI No. 619919, Dec. 15, 1994.
MacArthur et al. “Fgf-8, Activated by Proviral Insertion, Cooperates with theWnt-1Transgene in Murine Mammary Tumorignesis”J. of Virology69)4):2501-2507 (1995).
Moftah et al. “Ectodermal FGFs Induce Perinodular Inhibition of Limb Chondrogenesis in Vitro and in Vivo via FGF Receptor 2”Dev. Biol. 249:270-282 (2002).
Motulsky et al. “The Kinetics of Competitive Radioligand Binding Predicted by the Law of Mass Action”Mol. Pharmacol. 25:1-9 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

FGF-8 methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with FGF-8 methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FGF-8 methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4013455

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.